Chanmina will not perform at Music Awards Japan 2026's Grand Ceremony on June 13 at Tokyo's TOYOTA ARENA TOKYO, her agency announced. The trilingual artist was diagnosed with hypothyroidism-related throat issues after seeking medical care.

Following doctor's orders, Chanmina requires an extended recovery period and has decided to sit out the performance portion of the event. The artist's official website confirmed the diagnosis and emphasized that medical guidance made the withdrawal necessary.

The news comes as the domestic music industry gears up for one of Japan's largest international music awards. Music Awards Japan 2026 will still feature performances from other artists including Fujii Kaze, HANA, Yonezu Kenshi, and Sakanaction.

Chanmina, who raps and sings fluently in Japanese, Korean, and English, has built a solid career since her major debut in 2017. She's held sold-out shows at major venues including the Nippon Budokan in 2019 and Yokohama Arena in 2023, plus a two-day run at Pia Arena MM in 2024. Last summer, she released "20," a collaboration with Ash Island, and announced her marriage to the producer along with her first pregnancy.

Thyroid issues can significantly impact vocal performance, making her decision to prioritize health a responsible choice. Her withdrawal from Music Awards Japan 2026 gives her the time needed to recover properly under medical supervision.

Fans and industry colleagues have responded supportively to the announcement, understanding that health must come first. Chanmina's transparent communication about her condition—rare in an industry where artists often push through illness—sets a positive example for prioritizing wellbeing over scheduled appearances.